Effects of the Proton Pump Inhibitor, E3810, on Gastric Secretion and Gastric and Duodenal Ulcers or Erosions in Rats

This publication has 11 references indexed in Scilit:

• Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione
  Biochemical Pharmacology, 1991
• Binding site of omeprazole in hog gastric H+,K+-ATPase
  Biochemical and Biophysical Research Communications, 1990
• The potency of substituted benzimidazoles such as E3810, omeprazole, RO 18-5364 to inhibit gastric H+,K+-ATPase is correlated with the rate of acid-activation of the inhibitor
  Biochemical Pharmacology, 1990
• Acid activation of omeprazole in isolated gastric vesicles, oxyntic cells, and gastric glands
  Gastroenterology, 1989
• Opening Address
  Scandinavian Journal of Gastroenterology, 1989
• A Substituted Thieno[3.4-d]imidazole versus Substituted Benzimidazoles as H+, K+-ATPase Inhibitors
  Pharmacology, 1988
• The mechanism of action of the antisecretory agent omeprazole
  Journal of Medicinal Chemistry, 1986
• Biochemical and Pharmacological Analysis of 2-[(2-Dimethylaminobenzyl)Sulfinyl] Benzim dazole (NC-1300), a New Proton Pump Inhibitor
  The Japanese Journal of Pharmacology, 1986
• Omeprazole provides protection against experimentally induced gastric mucosal lesions
  European Journal of Pharmacology, 1983
• INFLUENCE OF VARIOUS FACTORS AND DRUGS ON CYSTEAMINE-INDUCED DUODENAL ULCERS IN THE RAT
  The Japanese Journal of Pharmacology, 1975